GOLDENWELL BIOTECH, INC. GWLL
OTC · stock · Food and Kindred Products · website · IPO 2021-12-07
GOLDENWELL BIOTECH, INC. statistics & valuation
Market cap$51.5M
Net margin-539038.2%
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Gross margin | 21.8% | 46.0% | 28.5% | 52.7% | 52.5% | — | — |
| Operating margin | -206047.3% | -88559.7% | -4949.8% | -2060.9% | -740.7% | — | — |
| Net margin | -539038.2% | -94602.9% | -5015.4% | -2060.9% | -732.6% | — | — |
| Return on assets | -820.8% | -58.7% | -51.5% | -396.6% | -25.4% | -2.5% | -0.9% |
| Return on equity | 86.3% | 278.4% | -139.3% | -488.6% | -38.8% | -2.5% | -0.9% |
| Debt / equity | — | -3.68× | 0.55× | — | — | — | — |
Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.